Home › Pharmacology › Hemostasis and Thrombosis

Hemostasis and Thrombosis

Q: Which blood coagulation factors are vitamin K-dependent?

The vitamin K-dependent coagulation factors include: Factor II (prothrombin).Factor VII (proconvertin).Factor IX (Christmas factor).Factor X (Stuart–Prower factor). Their functional activity requires γ-carboxylation, a process dependent on vitamin K. Proteins C and S are also vitamin K-dependent components of the anticoagulant system, though they are not classical clotting factors.

Q: Which natural anticoagulants circulate in blood plasma?

Natural anticoagulants include: Antithrombin III — a plasma protein that forms inactive complexes with serine proteases, including thrombin and factors IXa, Xa, and XIIa.Protein C — a vitamin K-dependent protein circulating in an active form; upon activation, it degrades factors VIIIa and Va.Protein S — a non-enzymatic cofactor for activated protein C.Tissue factor pathway inhibitor, $α_2$-macroglobulin, and $α_1$-antitrypsin — other natural inhibitors of coagulation factors.

Haemostasis

For medical students2 min readUpdated 2026-10-10

Hemostasis is a complex protective mechanism designed to stop bleeding upon vascular injury. It involves two parallel and interrelated processes: the formation of a primary platelet plug and the enzymatic coagulation cascade resulting in a stable fibrin network.

Platelet lifespanPlatelets circulate in the blood for 6–12 days before being cleared by tissue macrophages.

Reaction accelerationCofactors VIIIa and Va accelerate the catalytic rate of coagulation enzymes by a billion-fold.

Role of calciumCa2+ ions are critical for platelet aggregation and the binding of clotting factors to cell membranes.

HemodynamicsArterial thrombi are predominantly platelet-rich, whereas venous thrombi are predominantly fibrin-rich.

Primary Hemostasis: The Platelet Response

The process begins immediately upon endothelial injury, when subendothelial structures, primarily collagen, are exposed. Platelets respond with a series of sequential changes:

Adhesion. Platelets bind directly to collagen via GP Ia receptors and indirectly via von Willebrand factor, which acts as a bridge to GP Ib receptors.
Activation. Cells change shape from discoid to flattened, extending pseudopodia to increase contact surface area. Intracellular calcium ion ($Ca^{2+}$) concentration rises sharply.
Degranulation. Activated platelets release the contents of their granules into the blood: potent stimulators ADP and serotonin. Concurrently, they synthesize thromboxane A2 ($TxA_2$).
Aggregation. Released mediators act on neighboring cells via positive feedback. Under their influence, GP IIb/IIIa receptors undergo conformational changes and begin binding fibrinogen. Fibrinogen molecules cross-link platelets to form the primary plug.

Secondary Hemostasis: The Coagulation Cascade

Simultaneously with aggregation, the coagulation system is triggered. Its main objective is to reinforce the loose platelet plug with durable strands of fibrin. Most clotting factors are synthesized in the liver and circulate as inactive zymogens.

Initiation (Extrinsic Pathway). Upon vascular injury, blood contacts tissue factor (TF), which is normally sequestered in the subendothelium. This leads to the rapid activation of factor VII.
Reaction Cascade. The complex of active factor VIIa and TF activates factors IX and X. The process occurs on negatively charged phospholipid cell membranes and strictly requires calcium.
Thrombin Generation. Factor Xa converts prothrombin (factor II) to active thrombin (factor IIa).
Final Step. Thrombin cleaves fragments from soluble fibrinogen, converting it into insoluble fibrin. Fibrin strands polymerize, permeate the thrombus, and trap red blood cells, thus forming the definitive red thrombus.

Natural Anticoagulant Mechanisms

To prevent the thrombus from spreading to healthy vascular segments, intact endothelium actively suppresses hemostasis. Endothelial cells synthesize two major inhibitors:

Prostacyclin ($PGI_2$). Binds to platelet receptors, activates adenylate cyclase, and increases cAMP levels. This leads to a drop in intracellular calcium, causing GP IIb/IIIa receptors to lose their affinity for fibrinogen.
Nitric oxide (NO). Acts as an endothelium-derived relaxing factor, suppressing adhesion and aggregation.

Both substances inhibit platelet function and induce vasodilation. Upon vessel wall injury, the synthesis of these protective factors drops, shifting the balance toward thrombosis.

Principles of Pharmacological Correction

Understanding hemostatic mechanisms allows for targeted intervention in pathological states (bleeding disorders or thrombosis):

Thrombosis prevention: Antiplatelet agents (suppress platelet function) and anticoagulants (block plasma clotting factors) are used.
Lysis of existing thrombi: Thrombolytic agents are employed to activate plasminogen into plasmin, an enzyme that degrades fibrin.
Bleeding cessation: Pro-coagulant agents or antifibrinolytic drugs are administered.

Mnemonic

Remembering the major mediators is simple: ADP and Thromboxane A2 act as the "gas pedal" for platelets (increasing calcium and driving aggregation), while Prostacyclin acts as the "brake pedal" (decreasing calcium and inhibiting aggregation).

Frequently asked questions

What functions does thrombin perform during hemostasis?

Thrombin performs critical functions in the coagulation cascade, cellular activation, and coagulation regulation.

Platelet activation — serves as a potent aggregation inducer, stimulating degranulation and GP IIb/IIIa receptor expression.
Fibrin formation — converts soluble fibrinogen to insoluble fibrin, forming the fibrin clot.
Activation of plasma factors — activates several other blood coagulation factors.
Regulation of coagulation and fibrinolysis — participates in the activation of anticoagulants (forms a complex with thrombomodulin to activate protein C).
Proinflammatory action — increases endothelial permeability, stimulates mediator release from mast cells, and promotes anaphylatoxin C5a generation.

Which antithrombotic substances are synthesized by intact endothelium?

Intact endothelium synthesizes several substances that inhibit blood coagulation and platelet aggregation, as well as stimulate fibrinolysis.

Prostacyclin (PGI2) — a prostaglandin that inhibits platelet activation and aggregation.
Nitric oxide (NO) — an endothelium-derived relaxing factor that suppresses platelet adhesion and aggregation.
Tissue plasminogen activator (t-PA) — initiates thrombus lysis by converting plasminogen to plasmin.
Tissue factor pathway inhibitor — blocks the VIIa–TF–Ca²⁺ complex, preventing the activation of factors X and IX.

Which blood coagulation factors are vitamin K-dependent?

The vitamin K-dependent coagulation factors include:

Factor II (prothrombin).
Factor VII (proconvertin).
Factor IX (Christmas factor).
Factor X (Stuart–Prower factor).

Their functional activity requires γ-carboxylation, a process dependent on vitamin K. Proteins C and S are also vitamin K-dependent components of the anticoagulant system, though they are not classical clotting factors.

Which natural anticoagulants circulate in blood plasma?

Natural anticoagulants include:

Antithrombin III — a plasma protein that forms inactive complexes with serine proteases, including thrombin and factors IXa, Xa, and XIIa.
Protein C — a vitamin K-dependent protein circulating in an active form; upon activation, it degrades factors VIIIa and Va.
Protein S — a non-enzymatic cofactor for activated protein C.
Tissue factor pathway inhibitor, $α_2$-macroglobulin, and $α_1$-antitrypsin — other natural inhibitors of coagulation factors.

How do arterial and venous thrombi differ?

Due to high blood flow velocity, arterial thrombi are predominantly composed of aggregated platelets. In veins, blood flow is slower, allowing coagulation to dominate with the formation of fibrin-rich thrombi.

What role does thrombin play in hemostasis?

Thrombin fulfills two key functions: it converts soluble fibrinogen into insoluble fibrin strands and acts as a potent stimulator of platelet activation.

Why are clotting cofactors necessary?

Factors VIII and V are not enzymes themselves. Once activated by thrombin, they act as specific membrane-bound receptors, accelerating the catalytic activity of cascade enzymes by a billion-fold.

Go deeper

Biosynthesis and intracellular signal transduction of thromboxane A2
Mechanism of action of ADP via purinergic P2Y12 receptors
The role of cell membrane phospholipids in the activation of factors IXa and Xa
Physiological regulation of fibrinolysis: plasminogen and antiplasmins
Pathophysiology of hemostatic disorders: causes of hemorrhage and thrombosis